Disclosure of Voting results of AGM (Clause 35A)
Pfizer Ltd has informed BSE regarding the details of Voting results at the Annual General Meeting of the Company held on September 06, 2013, under Clause 35A.10-09-2013
10-09-2013
AGM on Sept 06, 2013
Pfizer Ltd has informed BSE that the 62nd Annual General Meeting (AGM) of the Company will be held on September 06, 2013.16-08-2013
Fixes Book Closure for Dividend & AGM
Pfizer Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from August 30, 2013 to September 06, 2013 (both days inclusive) for the purpose of Payment of Dividend & Annual General Meeting (AGM) of the Company to be held on September 06, 2013.The said dividend, if declared at the forthcoming Annual General Meeting, shall be paid on September 12, 2013.29-07-2013
Financial Results & Limited Review for June 30, 2013
Pfizer Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended June 30, 2013.27-07-2013
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Pfizer Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199215-05-2013
Appointment of Director
Pfizer Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 14, 2013, has appointed Mr S Sridhar as an Additional Director on the Board of the Company with effect from May 14, 2013.The appointment and remuneration of Mr S Sridhar, Whole-time Director will be subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company.15-05-2013
Financial Results & Auditors Report for March 31, 2013
Pfizer Ltd has informed BSE about the Financial Results & a copy of the Auditors Report for the period ended March 31, 2013.14-05-2013
Board recommends Normal Dividend & Special Dividend
Pfizer Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 14, 2013, inter alia, has recommended a normal dividend of Rs.12.50/- per Equity share of Rs.10/- each (125%) and special dividend of Rs. 20/- per Equity share of Rs. 10/- each (200%) on account of sale of animal health business aggregating to a total dividend of Rs. 32.50/- per Equity share of Rs. 10/- each (325%) for the year ended March 31, 2013,...14-05-2013
Postponement of Board Meeting on May 14, 2013
With reference to the earlier announcement dated April 23, 2013 regarding a meeting of the Board of Directors of the Company is scheduled on May 03, 2013, inter alia to consider and take on record the Audited Financial Results for the quarter and year ended March 31, 2013 and to recommend dividend, if any, thereon & also informed dated May 03, 2013 about the postponement of the said Board Meeting, Pfizer Ltd has now informed BSE that a meeting of...08-05-2013